203 related articles for article (PubMed ID: 16126324)
1. Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the tyrol screening project.
Pelzer AE; Bektic J; Berger AP; Halpern EJ; Koppelstätter F; Klauser A; Rehder P; Horninger W; Bartsch G; Frauscher F
Eur Urol; 2005 Dec; 48(6):916-21; discussion 921. PubMed ID: 16126324
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy.
Pelzer A; Bektic J; Berger AP; Pallwein L; Halpern EJ; Horninger W; Bartsch G; Frauscher F
J Urol; 2005 Jun; 173(6):1926-9. PubMed ID: 15879783
[TBL] [Abstract][Full Text] [Related]
3. Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?
Abdel-Khalek M; Sheir KZ; El-Baz M; Ibrahiem el-H
Scand J Urol Nephrol; 2005; 39(1):49-55. PubMed ID: 15764271
[TBL] [Abstract][Full Text] [Related]
4. Significance of routine transition zone biopsies in Japanese men undergoing transrectal ultrasound-guided prostate biopsies.
Miyake H; Kurahashi T; Muramaki M; Yamanak K; Hara I
Int J Urol; 2005 Nov; 12(11):964-8. PubMed ID: 16351652
[TBL] [Abstract][Full Text] [Related]
5. Frequency and clinical significance of transition zone cancer in prostate cancer screening.
Reissigl A; Pointner J; Strasser H; Ennemoser O; Klocker H; Bartsch G
Prostate; 1997 Feb; 30(2):130-5. PubMed ID: 9051151
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer screening in Tyrol, Austria: experience and results.
Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G
Eur Urol; 1999; 35(5-6):523-38. PubMed ID: 10325519
[TBL] [Abstract][Full Text] [Related]
7. Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score.
Mitterberger M; Pinggera GM; Horninger W; Bartsch G; Strasser H; Schäfer G; Brunner A; Halpern EJ; Gradl J; Pallwein L; Frauscher F
J Urol; 2007 Aug; 178(2):464-8; discussion 468. PubMed ID: 17561137
[TBL] [Abstract][Full Text] [Related]
8. Should transition zone biopsies be added to 12-core systematic biopsies of the prostate?
Hwang SI; Lee HJ; Cho JY; Kim SH; Lee SE; Byun SS; Hong SK; Choe GY
J Clin Ultrasound; 2009 Jun; 37(5):281-4. PubMed ID: 19309725
[TBL] [Abstract][Full Text] [Related]
9. Differences in biopsy features between prostate cancers located in the transition and peripheral zone.
Augustin H; Erbersdobler A; Graefen M; Jaekel T; Haese A; Huland H; Hammerer PG
BJU Int; 2003 Apr; 91(6):477-81. PubMed ID: 12656897
[TBL] [Abstract][Full Text] [Related]
10. Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol.
Durkan GC; Sheikh N; Johnson P; Hildreth AJ; Greene DR
BJU Int; 2002 Jan; 89(1):33-9. PubMed ID: 11849157
[TBL] [Abstract][Full Text] [Related]
11. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.
Guichard G; Larré S; Gallina A; Lazar A; Faucon H; Chemama S; Allory Y; Patard JJ; Vordos D; Hoznek A; Yiou R; Salomon L; Abbou CC; de la Taille A
Eur Urol; 2007 Aug; 52(2):430-5. PubMed ID: 17412489
[TBL] [Abstract][Full Text] [Related]
12. Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones.
Sakai I; Harada K; Kurahashi T; Yamanaka K; Hara I; Miyake H
Int J Urol; 2006 Apr; 13(4):368-72. PubMed ID: 16734852
[TBL] [Abstract][Full Text] [Related]
13. Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling.
Taverna G; Morandi G; Seveso M; Giusti G; Benetti A; Colombo P; Minuti F; Grizzi F; Graziotti P
BJU Int; 2011 Dec; 108(11):1723-7. PubMed ID: 21756276
[TBL] [Abstract][Full Text] [Related]
14. A prospective randomized trial comparing contrast-enhanced targeted versus systematic ultrasound guided biopsies: impact on prostate cancer detection.
Mitterberger M; Horninger W; Pelzer A; Strasser H; Bartsch G; Moser P; Halpern EJ; Gradl J; Aigner F; Pallwein L; Frauscher F
Prostate; 2007 Oct; 67(14):1537-42. PubMed ID: 17705242
[TBL] [Abstract][Full Text] [Related]
15. The potential impact of prostate volume in the planning of optimal number of cores in the systematic transperineal prostate biopsy.
Ficarra V; Novella G; Novara G; Galfano A; Pea M; Martignoni G; Artibani W
Eur Urol; 2005 Dec; 48(6):932-7. PubMed ID: 16202510
[TBL] [Abstract][Full Text] [Related]
16. The influence of prostate volume on prostate cancer detection using a combined approach of contrast-enhanced ultrasonography-targeted and systematic grey-scale biopsy.
Colleselli D; Bektic J; Schaefer G; Frauscher F; Mitterberger M; Brunner A; Schwentner C; Bartsch G; Horninger W; Pelzer AE
BJU Int; 2007 Dec; 100(6):1264-7. PubMed ID: 17850369
[TBL] [Abstract][Full Text] [Related]
17. Prostate biopsy: who, how and when. An update.
Djavan B; Milani S; Remzi M
Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
[TBL] [Abstract][Full Text] [Related]
18. Could the sextant prostate biopsy be replaced by transurethral resection?
Startsev VY; Pouline I; Gorelov S; Merkulova R
Arch Ital Urol Androl; 2005 Dec; 77(4):194-8. PubMed ID: 16444931
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer screening in the Tyrol, Austria: experience and results.
Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G
Eur J Cancer; 2000 Jun; 36(10):1322-35. PubMed ID: 10882875
[TBL] [Abstract][Full Text] [Related]
20. Critical evaluation of the current indications for transition zone biopsies.
Liu IJ; Macy M; Lai YH; Terris MK
Urology; 2001 Jun; 57(6):1117-20. PubMed ID: 11377321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
